Cancer Research The Future of Cancer Research: Science and Patient Impact  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Park, M.
Right arrow Articles by Shin, D. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Park, M.
Right arrow Articles by Shin, D. Y.
[Cancer Research 60, 542-545, February 1, 2000]
© 2000 American Association for Cancer Research


Advances in Brief

Constitutive Activation of Cyclin B1-associated cdc2 Kinase Overrides p53-mediated G2-M Arrest1

Misoon Park, Hee-Don Chae, Jeanho Yun, Moonsu Jung, Yeon-Soo Kim, Sung-Ho Kim, Moon Hi Han and Deug Y. Shin2

Bioscience Research Division, Korea Research Institute of Bioscience & Biotechnology, Yusung, Taejeon 305-333, Korea

Recent studies have suggested that p53 regulates the G2 checkpoint in the cell cycle and that this function is required for the maintenance of genomic integrity. In this study, we investigated a regulatory role of p53 specifically in G2-M transition. Human bladder carcinoma cells lacking functional p53 were synchronized at G1-S, which is preceded by p53-mediated G1 arrest. p53 expression in the synchronized cells was induced by infection with a recombinant adenovirus that encodes p53. After release from the G1-S arrest, the cells progressed to S-phase and G2 but failed to enter mitosis. Biochemical analysis showed that p53 inhibits cell cycle-dependent expression of cdc2 and cyclin B1 and consequently inhibits cdc2 kinase. The role of cyclin B1-associated cdc2 kinase in p53-mediated G2-M arrest was further investigated by expression of both cyclin B1 and cdc2AF, in which inhibitory phosphorylation sites were substituted. The cells expressing both cdc2AF and cyclin B1 showed a constitutive activation of cdc2 kinase during cell cycle progression and passed through G2-M regardless of p53 expression. Therefore, inactivation of cdc2 kinase through cdc2 and cyclin B1 repression is an essential step in p53-mediated G2-M arrest.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
Y. Song, C. Zhao, L. Dong, M. Fu, L. Xue, Z. Huang, T. Tong, Z. Zhou, A. Chen, Z. Yang, et al.
Overexpression of cyclin B1 in human esophageal squamous cell carcinoma cells induces tumor cell invasive growth and metastasis
Carcinogenesis, February 1, 2008; 29(2): 307 - 315.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. K. Ghosh, R. Steele, and R. B. Ray
Knockdown of MBP-1 in Human Prostate Cancer Cells Delays Cell Cycle Progression
J. Biol. Chem., August 18, 2006; 281(33): 23652 - 23657.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. S. Roberson, S. J. Kussick, E. Vallieres, S.-Y. J. Chen, and D. Y. Wu
Escape from Therapy-Induced Accelerated Cellular Senescence in p53-Null Lung Cancer Cells and in Human Lung Cancers
Cancer Res., April 1, 2005; 65(7): 2795 - 2803.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
L. W. Elmore, X. Di, C. Dumur, S. E. Holt, and D. A. Gewirtz
Evasion of a Single-Step, Chemotherapy-Induced Senescence in Breast Cancer Cells: Implications for Treatment Response
Clin. Cancer Res., April 1, 2005; 11(7): 2637 - 2643.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. Shats, M. Milyavsky, X. Tang, P. Stambolsky, N. Erez, R. Brosh, I. Kogan, I. Braunstein, M. Tzukerman, D. Ginsberg, et al.
p53-dependent Down-regulation of Telomerase Is Mediated by p21waf1
J. Biol. Chem., December 3, 2004; 279(49): 50976 - 50985.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H.-R. Lin, N. S. Y. Ting, J. Qin, and W.-H. Lee
M Phase-specific Phosphorylation of BRCA2 by Polo-like Kinase 1 Correlates with the Dissociation of the BRCA2-P/CAF Complex
J. Biol. Chem., September 19, 2003; 278(38): 35979 - 35987.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Yun, H.-D. Chae, T.-S. Choi, E.-H. Kim, Y.-J. Bang, J. Chung, K.-S. Choi, R. Mantovani, and D. Y. Shin
Cdk2-dependent Phosphorylation of the NF-Y Transcription Factor and Its Involvement in the p53-p21 Signaling Pathway
J. Biol. Chem., September 19, 2003; 278(38): 36966 - 36972.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Lohr, C. Moritz, A. Contente, and M. Dobbelstein
p21/CDKN1A Mediates Negative Regulation of Transcription by p53
J. Biol. Chem., August 29, 2003; 278(35): 32507 - 32516.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Polager and D. Ginsberg
E2F Mediates Sustained G2 Arrest and Down-regulation of Stathmin and AIM-1 Expression in Response to Genotoxic Stress
J. Biol. Chem., January 10, 2003; 278(3): 1443 - 1449.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. A. Hassan, K. K. Ang, A. K. El-Naggar, M. D. Story, J. I. Lee, D. Liu, W. K. Hong, and L. Mao
Cyclin B1 Overexpression and Resistance to Radiotherapy in Head and Neck Squamous Cell Carcinoma
Cancer Res., November 15, 2002; 62(22): 6414 - 6417.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. Farhana, M. Dawson, A. K. Rishi, Y. Zhang, E. Van Buren, C. Trivedi, U. Reichert, G. Fang, M. W. Kirschner, and J. A. Fontana
Cyclin B and E2F-1 Expression in Prostate Carcinoma Cells Treated with the Novel Retinoid CD437 Are Regulated by the Ubiquitin-mediated Pathway
Cancer Res., July 1, 2002; 62(13): 3842 - 3849.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Wang, J. Li, R. N. Booher, A. Kraker, T. Lawrence, W. R. Leopold, and Y. Sun
Radiosensitization of p53 Mutant Cells by PD0166285, a Novel G2 Checkpoint Abrogator
Cancer Res., November 1, 2001; 61(22): 8211 - 8217.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
X.-Y. Yin, L. Grove, N. S. Datta, K. Katula, M. W. Long, and E. V. Prochownik
Inverse Regulation of Cyclin B1 by c-Myc and p53 and Induction of Tetraploidy by Cyclin B1 Overexpression
Cancer Res., September 1, 2001; 61(17): 6487 - 6493.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J.-C. Soria, S. J. Jang, F. R. Khuri, K. Hassan, D. Liu, W. K. Hong, and L. Mao
Overexpression of Cyclin B1 in Early-Stage Non-Small Cell Lung Cancer and Its Clinical Implication
Cancer Res., August 1, 2000; 60(15): 4000 - 4004.
[Abstract] [Full Text]


Home page
Mol. Cell. Biol.Home page
P. M. Flatt, L. J. Tang, C. D. Scatena, S. T. Szak, and J. A. Pietenpol
p53 Regulation of G2 Checkpoint Is Retinoblastoma Protein Dependent
Mol. Cell. Biol., June 15, 2000; 20(12): 4210 - 4223.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
I. Manni, G. Mazzaro, A. Gurtner, R. Mantovani, U. Haugwitz, K. Krause, K. Engeland, A. Sacchi, S. Soddu, and G. Piaggio
NF-Y Mediates the Transcriptional Inhibition of the cyclin B1, cyclin B2, and cdc25C Promoters upon Induced G2 Arrest
J. Biol. Chem., February 16, 2001; 276(8): 5570 - 5576.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Casalini, L. Botta, and S. Menard
Role of p53 in HER2-induced Proliferation or Apoptosis
J. Biol. Chem., April 6, 2001; 276(15): 12449 - 12453.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.